首页> 外国专利> Expression of human Foxp3 in gene editing T cells

Expression of human Foxp3 in gene editing T cells

机译:人Foxp3在基因编辑T细胞中的表达

摘要

The aspect of the invention described herein relates to the generation of Foxp3 in a human primary lymphoid or under control by targeting Foxp3 cDNA (e.g., the full length of Foxp3 cDNA optimized for human codon) to the FOXP3 locus or non Foxp3 locus.The compositions and materials described herein provide specificity for control of mice, non human primates, or fofox3 genes in humans through cripr / CAS.Using a guide RNA sequence, the FOXP3 locus, aavs1 locus, and other candidate loci are targeted to perform gene regulation through CRISPR / CAS and provide gene delivery cassettes for gene modification based on homologous recombination repair.The alternative compositions described herein can be delivered in the form of ribonucleoprotein (RNP) and may be used to target Foxp3 of human and / or non human primates.The reagent is composed of a novel guide RNA sequence, which can be used to generate an on target cleavage at high frequencies by combining with a novel gene delivery cassette and a CAS protein comprising Foxp3 cDNA and / or other CIS configuration gene products.
机译:本文所述的本发明的方面涉及通过靶向FOXP3 cDNA(例如,针对人密码子优化的FoxP3 cDNA的全长Foxp3 cDNA)在禽诊断或非FOXP3基因座中产生FoxP3。组合物通过CRIPR / CAS,本文所述的材料提供了对人类中的小鼠,非人类原始化物或FOFOX3基因的特异性。使用引导RNA序列,FoxP3基因座,AAVS1基因座和其他候选基因座通过CRISPR来进行基因调节/ CAS并为基于同源重组修复提供基因改性的基因递送盒。本文所述的替代组合物可以以核糖核蛋白(RNP)的形式递送,并且可用于靶向人和/或非人类灵长类动物的FOXP3。试剂由新型指导RNA序列组成,可用于通过与新的基因输送盒组合来生成高频上的靶裂解包含Foxp3 cDNA和/或其他顺式构型基因产物的CAS蛋白。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号